Clinical Trials

AXADIA - AFNET 8 Studie
A Safety Study Assessing Oral Anticoagulation with Apixaban versus Vitamin-K Antagonists in Patients with Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD) on Chronic Hemodialysis Treatment (AXADIA)
ONGOING TRIAL

OCEAN Trial
The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial (OCEAN)
ONGOING TRIAL

NOAH - AFNET 6 Trial
Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes
ONGOING TRIAL

AXAFA – AFNET 5 Trial
Anticoagulation using the direct factor Xa inhibitor apixaban during Atrial Fibrillation catheter Ablation: Comparison to vitamin K antagonist therapy.
ONGOING TRIAL

EAST – AFNET 4 Trial
Early treatment of atrial fibrillation for stroke prevention trial (EAST)
ONGOING TRIAL

RE-LATED AF – AFNET 7 Trail
Resolution of Left Atrial-Appendage Thrombus – Effects of Dabigatran in patients with Atrial Fibrillation (RE-LATED AF)
ONGOING TRIAL

 

 

Flec-SL – AFNET 3 Trial
Short-term pharmacological reversal of atrial fibrillation
COMPLETED TRIAL

ANTIPAF – AFNET 2 Trial
Angiotensin II receptor antagonist in paroxysmal atrial fibrillation trial
COMPLETED TRIAL

Gap-AF – AFNET 1 Trial
Catheter ablation of atrial fibrillation
COMPLETED TRIAL

BACE-PACE Trial
Preventive pacing in combination with beta-blocker or AT-I-/ACE-inhibitor therapy on the recurrence of atrial fibrillation in patients with dual-chamber pacemakers
COMPLETED TRIAL